| SKU | ISG014456 |
| Brand | Cinnarizine |
| Color | black |
| Shop by Concerns | Cerebrovascular Symptoms |
| Gender | Neutral |
| Shop By Goals | Motion Sickness Relief |
| Imported Or Local | Local |
| Ingredient | Cinnarizine |
| Specialty | Antihistamine Anti Vertigo Calcium Channel Blocker Effect |
| Warning | Keep Out of Reach of Children Consult a doctor if pregnant or breastfeeding Do not exceed recommended dose May cause drowsiness; avoid driving Use with caution in elderly and neurological conditions |
Cinnarizine 25 mg 20 tablets
Description:
Cinnarizine 25 mg 20 tablets is an oral prescription medicine containing the antihistamine and antivertigo agent cinnarizine. It is primarily used to prevent and treat motion sickness, vertigo, and other balance disorders, as well as to support the management of certain peripheral and cerebrovascular circulation problems. By blocking H1 histamine receptors and calcium channels in vascular smooth muscle, cinnarizine helps reduce dizziness, nausea, vomiting, and improves blood flow in specific vascular conditions. This product is intended for adult use under medical supervision.
Indications:
- Prevention and treatment of motion sickness (travel sickness), including nausea, vomiting, and dizziness associated with travel by car, sea, or air.
- Treatment of vertigo and other vestibular disturbances (inner ear balance disorders), such as dizziness, spinning sensation, and balance problems.
- Adjunctive treatment of vomiting and vertigo in Meniere's disease and similar inner ear conditions, as prescribed by a doctor.
- Treatment of certain vascular disorders (peripheral and cerebrovascular), such as symptoms related to impaired blood flow (e.g., cold extremities, intermittent claudication, tinnitus, and certain types of headache), as directed by a physician.
Active Ingredients / Key Components:
- Cinnarizine – 25 mg per tablet.
- Excipients: Other inactive ingredients (tablet core and coating excipients) are present but not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.).
Dosage & Administration / How to Use:
- Always use exactly as prescribed by your doctor or as directed on the product label. Do not exceed the recommended dose.
- Adults – Motion sickness: Typical regimen: 30 mg taken 2 hours before the start of the journey, then, if needed, 15–30 mg every 8 hours during travel. For this 25 mg tablet strength, your doctor will adjust the dose (e.g., 1 tablet ≈ 25 mg). Follow your physician’s instructions.
- Adults – Vertigo and vestibular disturbances, vomiting in Meniere's disease: Usual total daily dose is 90 mg per day in 3 divided doses. With 25 mg tablets, your doctor will determine the exact number of tablets and dosing schedule.
- Adults – Peripheral and cerebrovascular disorders: Typical dose is 75 mg 1–3 times daily. Your physician will adapt this to the 25 mg tablet strength.
- Tablets are usually taken by mouth with water, preferably after meals to reduce the risk of stomach upset.
- Do not crush or chew the tablets unless advised by your doctor.
- If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
- Duration of treatment depends on the condition being treated and your doctor’s recommendation. Do not use for prolonged periods without medical supervision.
Clinical Benefits:
- Helps prevent and relieve motion sickness symptoms such as nausea, vomiting, and dizziness during travel.
- Reduces vertigo and balance disturbances by suppressing vestibular (inner ear) overactivity.
- Provides antivertigo and anti-nausea effects in conditions like Meniere’s disease and other inner ear disorders.
- Contributes to the management of certain peripheral and cerebrovascular circulation problems by inhibiting calcium influx in vascular smooth muscle and improving blood flow.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity or allergy to cinnarizine or any of the excipients.
- Use with caution in patients with Parkinson’s disease or other extrapyramidal disorders, as cinnarizine may worsen symptoms.
- May cause drowsiness or dizziness. Avoid driving, operating machinery, or performing tasks requiring alertness until you know how the medicine affects you.
- Use with caution in elderly patients, as they may be more susceptible to side effects such as sedation and movement disorders.
- Consult your doctor before use if you have liver disease, kidney impairment, low blood pressure, or any neurological or psychiatric conditions.
- Alcohol and other central nervous system depressants may enhance drowsiness; avoid or limit concurrent use.
- Pregnancy and breastfeeding: Use only if clearly needed and prescribed by a doctor. Safety data in pregnancy and lactation are limited.
- Not usually recommended for children unless specifically prescribed by a pediatric specialist.
- Do not exceed the prescribed dose or use for longer than recommended without medical advice.
- Keep out of reach of children.
Side Effects:
- Common side effects: Drowsiness, fatigue, dry mouth, mild gastrointestinal discomfort (nausea, stomach pain), weight gain, headache.
- Less common side effects: Sweating, skin rash or allergic reactions, muscle pain, mild hypotension (low blood pressure).
- Serious side effects (seek medical attention immediately): Signs of severe allergic reaction (swelling of face, lips, tongue, or throat; difficulty breathing), severe dizziness or fainting, new or worsening tremors, stiffness, or other movement disorders, confusion or significant mood changes.
- If any side effect persists, worsens, or you notice any unusual symptoms, stop taking the medicine and consult your doctor or pharmacist.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Do not store above the temperature specified on the package (information not available in the provided data; follow pack instructions).
Specifications:
- Strength: 25 mg cinnarizine per tablet.
- Form: Oral tablets.
- Pack size: 20 tablets per pack.
- Intended use: Prescription or pharmacist-supervised medicine for motion sickness, vertigo, and certain vascular disorders in adults.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

